The strategic stock of pharmaceuticals in the UAE is robust and sufficient to meet local market needs, as emphasized by Dr. Fatima Al Kaabi, the Director General of the UAE’s Medicine Foundation. With a thriving network of local pharmaceutical manufacturers, the country has fortified its drug security framework, contributing significantly to the national economy. This article delves into the state of the pharmaceutical sector in the UAE, showcasing its capacity and readiness to ensure a steady supply of medications amidst evolving global and regional challenges.
Strengthening Local Manufacturing
Dr. Fatima Al Kaabi highlighted the critical role of local pharmaceutical and medical supply manufacturers in maintaining drug security within the UAE. During her recent visit to several pharmaceutical factories, she assessed their production capabilities and future expansion plans. She stated, “The pharmaceutical sector in the UAE enjoys stability and readiness, thanks to an advanced system that ensures the sustainability of medication availability for the community, adhering to the highest quality and safety standards.” The assurance that the strategic stock of pharmaceuticals is safe and sufficient has been a cornerstone of maintaining public health resilience.
Responsive and Efficient Pharmaceutical Framework
The UAE’s pharmaceutical ecosystem has demonstrated an ability to effectively respond to various regional and global changes. Dr. Al Kaabi stressed that the nation has successfully enhanced the capacities of local pharmaceutical factories while establishing regulations that encourage development in the sector. This dual approach not only strengthens the strategic stock of pharmaceuticals but also fosters innovation and growth within the industry.
Commitment to Quality and Safety
During her tour, Dr. Al Kaabi received detailed explanations from factory representatives regarding current production capacities and future plans, as well as the advanced technologies employed in manufacturing processes. This evaluation showcased the local pharmaceutical industry’s increasing role in stabilizing the national drug market and enhancing the sustainability of supply chains. The commitment to maintaining the strategic stock of pharmaceuticals aligns with national goals for health security and economic stability.
Industry Insights from Local Leaders
The Director General of Medisal Pharma, Neha Srivastava, expressed pride in the company’s operations based in Abu Dhabi, emphasizing their contribution to the UAE’s pharmaceutical manufacturing ecosystem. She praised the UAE Medicine Foundation for its role in bolstering the readiness of local factories and enhancing cooperation among manufacturers. “The UAE possesses a solid pharmaceutical base supported by a developed and stable regulatory environment,” she noted, affirming that Medisal Pharma remains committed to ensuring their products are always available in the market, preventing any shortages in the context of national drug security.
Similarly, Vukion Sinis, CEO of Adkan Pharma, highlighted the essential role of local pharmaceutical manufacturing in ensuring the continuous availability of medications amid increasing global supply chain pressures. He reiterated the company’s commitment to providing adequate quantities of pharmaceutical products to meet local demands. Adkan Pharma continues to collaborate closely with the UAE Medicine Foundation to enhance production capabilities and deliver high-quality medications that meet the highest standards of quality and safety.
Through these efforts, the strategic stock of pharmaceuticals remains not only a priority but a fundamental aspect of the UAE’s approach to healthcare and economic robustness. A strong and resilient pharmaceutical sector is poised to meet the needs of the population and support public health initiatives across the nation.